127 related articles for article (PubMed ID: 7405982)
1. Improvement in artificial second-trimester abortion with a new tissue-selective prostaglandin E2 derivative.
Schmidt-Gollwitzer R; Schuessler B; Elger W; Schmidt-Gollwitzer M
Am J Obstet Gynecol; 1980 Aug; 137(7):867-8. PubMed ID: 7405982
[TBL] [Abstract][Full Text] [Related]
2. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
Schmidt-Gollwitzer K; Schüssler B; Elger W; Schmidt-Gollwitzer M
Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
[TBL] [Abstract][Full Text] [Related]
3. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
Nilsson S; Zador G; Nygren KG; Wide L
Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
[TBL] [Abstract][Full Text] [Related]
4. Termination of normal and pathological pregnancy with Sulprostone.
Fischer Z; Chwalisz K; Michałkiewicz W
Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
[TBL] [Abstract][Full Text] [Related]
5. Abortion with sulprostone, a prostaglandin E2 derivative.
Pulkkinen MO; Kajanoja P; Kivikoski A; Saastamoinen J; Selander K; Tuimala R
Int J Gynaecol Obstet; 1980; 18(1):40-3. PubMed ID: 6106599
[TBL] [Abstract][Full Text] [Related]
6. First and midtrimester abortion with intramuscular injections of sulprostone.
Ballard CA
Contraception; 1981 Aug; 24(2):145-50. PubMed ID: 7297066
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and acceptability of intravenously administered sulprostone, a tissue-selective prostaglandin-E2 derivative, for induction of first-trimester abortion.
Schuessler B; Schmidt-Gollwitzer K; Hoebich D; Schmidt-Gollwitzer M
Contraception; 1979 Jan; 19(1):29-38. PubMed ID: 428222
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
[TBL] [Abstract][Full Text] [Related]
9. The vaginal administration of 9-deoxo-16,16-dimethyl-9-methylene PGE2 for second trimester abortion.
Ballard CA
Contraception; 1981 Aug; 24(2):151-7. PubMed ID: 7297067
[TBL] [Abstract][Full Text] [Related]
10. [Induction of abortion during the second and third trimester of pregnancy with sulprostone (author's transl)].
Heinzl S; Winkler C
Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):231-6. PubMed ID: 7215768
[TBL] [Abstract][Full Text] [Related]
11. Uterine motility and cervical ripening in second trimester elective abortion by two different PGE analogues.
Di Lieto A; Catalano D; Albano G; Uccello N; Civetta A; Ferrara R; Fimiani R; Pontillo M; Paladini A
Clin Exp Obstet Gynecol; 1991; 18(4):251-9. PubMed ID: 1790608
[TBL] [Abstract][Full Text] [Related]
12. Low-dose sulprostone for pregnancy termination in cases of fetal abnormality.
Kanhai HH; Keirse MJ
Prenat Diagn; 1993 Feb; 13(2):117-21. PubMed ID: 8464832
[TBL] [Abstract][Full Text] [Related]
13. [Termination of pregnancy in the 2nd trimester using intra-amniotic administration of prostaglandins].
Krofta L; Calda P; Zizka Z; Parízek A; Hrusková H; Kapras J
Ceska Gynekol; 1998 Oct; 63(5):414-7. PubMed ID: 9818502
[TBL] [Abstract][Full Text] [Related]
14. Induction of abortion with sulprostone, a uteroselective prostaglandin E2 derivative: intramuscular route of application.
Schmidt-Gollwitzer K; Hoebich D; Hardt W; Schuessler B; Schmidt-Gollwitzer M
Int J Fertil; 1981; 26(2):86-93. PubMed ID: 6114070
[TBL] [Abstract][Full Text] [Related]
15. Termination of second trimester pregnancy with intraamniotic administration of 16-phenoxy-omega-tetranor-PgE2-methylsulfonamide (SHB 286) alone and combined with oxytocin and calcium gluconate.
van den Bergh AS; Haspels AA
Contraception; 1978 Dec; 18(6):635-9. PubMed ID: 750189
[TBL] [Abstract][Full Text] [Related]
16. Termination of second trimester pregnancy by intramuscular injection of 16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methyl sulphonylamide.
Int J Gynaecol Obstet; 1982 Oct; 20(5):383-6. PubMed ID: 6128270
[TBL] [Abstract][Full Text] [Related]
17. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
Kirz DS; Haag MK
Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of sulprostone for second trimester abortions and its effects on liver and kidney function.
Ranjan V; Hingorani V; Kinra G; Agarwal N; Pande Y
Contraception; 1982 Feb; 25(2):175-84. PubMed ID: 7075190
[TBL] [Abstract][Full Text] [Related]
19. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
Bolognese RJ; Corson SL
Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
[TBL] [Abstract][Full Text] [Related]
20. Biological action and half life in plasma or intramuscular sulprostone for termination of second trimester pregnancy.
Briel RC; Lippert TH
Prostaglandins Med; 1981 Jan; 6(1):1-8. PubMed ID: 7220653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
